An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT) [Methylation]

ABSTRACT: An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT) [Methylation]

PROVIDER: PRJNA1190925 | ENA |

REPOSITORIES: ENA